Day One Biopharmaceuticals, Inc. (DAWN)

NASDAQ: DAWN · Real-Time Price · USD

7.01

+0.63 (9.87%)

At close: Jun 2, 2025, 4:00 PM

7.08

+0.07 (1.00%)

After-hours: Jun 2, 2025, 6:28 PM EDT

Revenue by Product

Fiscal year is January - December.

Fiscal Year	FY 2024
Period Ending	Dec '24 Dec 31, 2024
Medicines for Childhood and Adult Diseases with Equal Intensity	131.16M

Revenue by Geography

Fiscal year is January - December.

Fiscal Year	FY 2024
Period Ending	Dec '24 Dec 31, 2024
United States	131.16M